Percutaneous drainage and sclerotherapy as definitive treatment of

Authors

  • Massimo Valerio Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
  • Jean-Yves Meuwly Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
  • Cecile Tawadros Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
  • Patrice Jichlinski Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

DOI:

https://doi.org/10.5489/cuaj.334

Abstract

We report the technique and outcome of percutaneous drainage
and sclerotherapy as primary treatment of renal lymphangiomatosis. Between January and May 2009, two patients presenting with symptomatic renal lymphangiomatosis were treated in our department by a minimally invasive modality combining percutaneous drainage with repeated sclerotherapy. We retrospectively analysed recurrence, complications and patient satisfaction. In this limited case series, percutaneous drainage and repeated sclerotherapy proved to be safe and effective for treating renal lymphangiomatosis. This procedure provides a minimally invasive option for selected patients, potentially avoiding a surgical procedure and any risk of complications.

Downloads

Download data is not yet available.

Author Biographies

Massimo Valerio, Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Jean-Yves Meuwly, Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Cecile Tawadros, Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Patrice Jichlinski, Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Downloads

Published

2013-02-24

How to Cite

Valerio, M., Meuwly, J.-Y., Tawadros, C., & Jichlinski, P. (2013). Percutaneous drainage and sclerotherapy as definitive treatment of. Canadian Urological Association Journal, 6(1), E3-E7. https://doi.org/10.5489/cuaj.334

Issue

Vol. 6 No. 1 (2012): CUAJ February

Section

Case Report

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.